Cross-sectional study to describe allergic rhinitis flare-ups and associated airways phenotype in house dust mite sensitization
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283246 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Ludovic de Gabory und 5 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Department, Hôpital Pellegrin, University Hospital of Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Sublingual Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Allergologisk Laboratorium København Société par Actions Simplifiées.
Abstract (Originalsprache)
Objectives
To quantify and describe flare-ups of house dust mite allergic rhinitis (HDM-AR) which had occurred during the last 12 months in a population of adults and children candidate for Allergen ImmunoTherapy (AIT). Next, to identify associated clinical features. Materials and methods This was an observational, multicenter, cross-sectional study that included patients aged ≥ 5 years with HDM-AR eligible for AIT and without prior AIT for at least 12 months. Flare-ups were all period with impairment of quality of life (QoL) and requiring a change in their usual treatment. Data were collected using medical records and patient questionnaires. Variables associated with the occurrence of ≥ 2 AR flare-ups were identified.
Results
1,701 patients were included (average age: 23 years, 51.5% males, 30.4% children, 17.7% adolescents and 51.9% adults). Severe and persistent AR affected 70.9% of them and 53.7% showed polysensitization. Asthma was associated with AR in 34.4% and was well-controlled in 58.5%. The occurrence of at least one AR flare-up in the year was reported by 77.7%, with an annual rate in the whole population of 2.6 ± 3.9 and a duration of 14.1 ± 17.1 days. Deeply or moderately AR-related degraded QoL was experienced by 39.5% and 64.6%, respectively. The occurrence of ≥ 2 AR flare-ups was reported by 54.5% and was associated with polysensitization, AR intermittence and severity.
Conclusion
AR flare-ups are frequent and impair QoL in HDM-allergic patients, suggesting that it could be considered as therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Otorhinolaryngology Department, Hôpital Pellegrin, University Hospital of Bordeaux, Bordeaux, France.
- Direction Médicale, Allergologisk Laboratorium København Société par Actions Simplifiées (ALK SAS), La Défense, France.
- Direction Médicale, Axonal, Nanterre, France.
- Service de Pneumologie et Immuno-Allergologie, CHU de Lille, Univ. Lille, CNRS, Inserm, Institut Pasteur de Lille U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, CRISALIS / F-CRIN INSERM Network, L…
ORCID-Profile: Sabine Amet, Jean-Pierre Meunier
Förderung
- Allergologisk Laboratorium København Société par Actions Simplifiées
Zitieren
APA
de Gabory, L., Amet, S., Le Maux, A., Meunier, J. P., Chartier, A., & Chenivesse, C. (2023). Cross-sectional study to describe allergic rhinitis flare-ups and associated airways phenotype in house dust mite sensitization. PLOS ONE. https://doi.org/10.1371/journal.pone.0283246
Vancouver
de Gabory L, Amet S, Le Maux A, Meunier JP, Chartier A, Chenivesse C. Cross-sectional study to describe allergic rhinitis flare-ups and associated airways phenotype in house dust mite sensitization. PLOS ONE. 2023. doi:10.1371/journal.pone.0283246
BibTeX
@article{deGabory2023,
author = {de Gabory, Ludovic and Amet, Sabine and Le Maux, Annelore and Meunier, Jean-Pierre and Chartier, Antoine and Chenivesse, Cécile},
title = {Cross-sectional study to describe allergic rhinitis flare-ups and associated airways phenotype in house dust mite sensitization},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283246}
}
EUVIMED